Clinical trialNCT00773474TerminatedPhase 2Interventional

Lonafarnib in Metastatic Breast Cancer

SponsorGeorge SledgeEnrollment29Metastatic Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brian Leland-Jones, M.D.
Hoosier Cancer Research Network
Principal Investigator
clinicaltrials.gov ↗
George Sledge, M.D.
Hoosier Cancer Research Network
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
Cancer Care Center of Southern Indiana
Bloomington, Indiana, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Arnett Cancer Care
Lafayette, Indiana, United States
Horizon Oncology Center
Lafayette, Indiana, United States
Ireland Cancer Center - University Hospitals of Cleveland
Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2008
Primary completion: 30 Nov 2010
Completion: 30 Nov 2010
Last update posted: 18 Feb 2016
Registered enrollment: 29
Registry id: NCT00773474

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.